Submitted by Anonymous (not verified) on 10 December 2025 - 14:30
Human medicines European public assessment report (EPAR): Eydenzelt, aflibercept, Date of authorisation: 12/02/2025, Revision: 3, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Eydenzelt, aflibercept, Date of authorisation: 12/02/2025, Revision: 3, Status: Authorised